Physician profile
Maxine Hawk
NPI 1811346422
$3,247.56
in general payments reported to CMS, 2019-2025
16 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $334 · 2022: $262 · 2023: $2,049 · 2024: $428 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,395 · Travel and Lodging: $1,202 · Education: $54.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,394.74 |
| Travel and Lodging | $1,202.39 |
| Education | $54.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,029.31 | 2023-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Collegium Pharmaceutical, INC. | $383.14 | 2021-2025 | Belbuca, Xtampza |
| Boston Scientific Corporation | $297.32 | 2021-2024 | Intracept |
| Nevro Corp. | $167.54 | 2021-2024 | Senza |
| Ani Pharmaceuticals, INC. | $94.17 | 2024-2025 | Purified Cortrophin Gel |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.23 | 2021-2022 | |
| Horizon Therapeutics Plc | $47.84 | 2021-2022 | |
| Spr Therapeutics, INC | $32.93 | 2022-2024 | Sprint Pns System |
| Nalu Medical, INC. | $27.31 | 2022-2023 | Nalu Neurostimulation System |
| Saluda Medical Americas, INC. | $20.96 | 2024 | Evoke |
| Bioventus LLC | $19.73 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.36 | 2022 | |
| Averitas Pharma INC. | $14.81 | 2023 | Qutenza |
| Lilly USA, LLC | $13.22 | 2021 | |
| Grt US Holding, INC. | $12.36 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $7.33 | 2023 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maxine Hawk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.